psalexa
logo

PD-1 & PD-L1 Inhibitors Pipeline Analysis

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

Published: January 2017
Report Code: LS10752
Available Format:
Pages: 168

Note: This report can also be updated as of date and delivered within 1-2 workings days of purchase confirmation

The research offers pipeline analysis as of the year 2016, historical market size for the year 2014 and 2015, estimate for the year 2016 and forecast for the period 2017 – 2025 in terms of U.S. dollars.

GLOBAL PD-1 & PD-L1 INHIBITORS PIPELINE ANALYSIS

  • By mechanism of action (MoA)
  • By molecule type
  • By route of administration
  • By company
  • By phase

GLOBAL PD-1 & PD-L1 INHIBITORS MARKET

  • By drug
  • By MoA

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 6500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 7500
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 10500

Pre-Purchase Enquiry